Tanaz Sharifnia is a research scientist and investigator in the Chemical Biology and Therapeutics Science Program at the Broad Institute of Harvard and MIT. Her research interests include applying systematic functional genomic and small-molecule-based approaches to discover and target cancer vulnerabilities. Working in close partnership with other scientists, clinicians, a medical research foundation, and patients, she seeks to translate basic research insights into new therapies for patients with intractable cancers. Dr. Sharifnia received her Ph.D. in the field of cancer genomics from Harvard University.